{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T13:58:12Z","timestamp":1774360692986,"version":"3.50.1"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[1985,1,1]],"date-time":"1985-01-01T00:00:00Z","timestamp":473385600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Infection"],"published-print":{"date-parts":[[1985,1]]},"DOI":"10.1007\/bf01644225","type":"journal-article","created":{"date-parts":[[2005,5,7]],"date-time":"2005-05-07T07:33:08Z","timestamp":1115451188000},"page":"S81-S88","source":"Crossref","is-referenced-by-count":36,"title":["Gram-positive superinfections following beta-lactam chemotherapy: The significance of the enterococcus","Superinfektionen mit grampositiven Keimen nach Therapie mit \u03b2-Lactam-Antibiotika: Bedeutung der Enterokokken"],"prefix":"10.1007","volume":"13","author":[{"given":"R. N.","family":"Jones","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1093\/jac\/6.6.775","volume":"6","author":"A. L. Barry","year":"1980","unstructured":"Barry, A. L., Thornsberry, E., Jones, R. N. In vitro evaluation of LY127935 (6059S) compared to cefotaxime, eight other beta lactams and two aminoglycosides. J. Antimicrob. Chemother. 6 (1980) 775\u2013784.","journal-title":"J. Antimicrob. Chemother."},{"key":"CR2","doi-asserted-by":"crossref","first-page":"755","DOI":"10.7326\/0003-4819-97-5-755","volume":"97","author":"G. M. Eliopoulos","year":"1982","unstructured":"Eliopoulos, G. M., Moellering, R. C. Azlocillin, mezlocillin, and piperacillin: New broad-spectrum penicillins. Ann. Intern. Med. 97 (1982) 755\u2013760.","journal-title":"Ann. Intern. Med."},{"key":"CR3","doi-asserted-by":"crossref","unstructured":"Jones, R. N.: A review of thein vitro spectrum of imipenem. Am. J. Med. (1985) in print.","DOI":"10.1016\/0002-9343(85)90098-1"},{"issue":"Suppl.","key":"CR4","doi-asserted-by":"crossref","first-page":"S108","DOI":"10.1093\/clinids\/5.Supplement_1.S108","volume":"5","author":"R. N. Jones","year":"1983","unstructured":"Jones, R. N., Barry, A. L. Cefoperazone sodium: a review of thein vitro characteristics, antimicrobial spectrum, beta-lactamase stability and enzyme inhibition. Rev. Infect. Dis. 5 Suppl. (1983) S108-S126.","journal-title":"Rev. Infect. Dis."},{"issue":"Suppl. B","key":"CR5","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1093\/jac\/8.suppl_B.187","volume":"8","author":"R. N. Jones","year":"1981","unstructured":"Jones, R. N., Barry, A. L., Thornsberry, C., Gerlach, E. H., Fuchs, P. C., Gavan, T. L., Sommers, H. M. Ceftazidime (GR20263), a pseudomonas-active cephalosporin:in vitro antimicrobial activity evaluation including recommendations for disk diffusion susceptibility tests. J. Antimicrob. Chemother. 8 Suppl. B (1981) 187\u2013211.","journal-title":"J. Antimicrob. Chemother."},{"issue":"Suppl.","key":"CR6","doi-asserted-by":"crossref","first-page":"S300","DOI":"10.1093\/clinids\/4.Supplement_2.S300","volume":"4","author":"R. N. Jones","year":"1982","unstructured":"Jones, R. N., Thornsberry, C. Cefotaxime (HR756): a review of thein vitro antimicrobial properties and spectrum of activity. Rev. Infect. Dis. 4 Suppl. (1982) S300-S315.","journal-title":"Rev. Infect. Dis."},{"issue":"Suppl.","key":"CR7","doi-asserted-by":"crossref","first-page":"S708","DOI":"10.1093\/clinids\/4.Supplement_3.S708","volume":"4","author":"R. C. Moellering Jr.","year":"1982","unstructured":"Moellering, R. C. Jr. Enterococcal infections in patients treated with moxalactam. Rev. Infect. Dis. 4 Suppl. (1982) S708-S711.","journal-title":"Rev. Infect. Dis."},{"issue":"Suppl.","key":"CR8","doi-asserted-by":"crossref","first-page":"S165","DOI":"10.1093\/clinids\/5.Supplement_1.S165","volume":"5","author":"I. M. Baird","year":"1983","unstructured":"Baird, I. M. Multicentered study of cefoperazone for treatment of intraabdominal infections and comparison of cefoperazone with cefamandole and clindamycin plus gentamicin for treatment of appendicitis and peritonitis. Rev. Infect. Dis. 5 Suppl. (1983) S165-S172.","journal-title":"Rev. Infect. Dis."},{"issue":"Suppl. 1B","key":"CR9","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0002-9343(84)80094-7","volume":"77","author":"M. S. Cohen","year":"1984","unstructured":"Cohen, M. S., Washton, H. E., Barranco, S. F. Multicenter clinical trial of cefoperazone sodium in the United States. Am. J. Med. 77 Suppl. 1B (1984) 35\u201341.","journal-title":"Am. J. Med."},{"issue":"Suppl.","key":"CR10","doi-asserted-by":"crossref","first-page":"S145","DOI":"10.1093\/clinids\/5.Supplement_1.S145","volume":"5","author":"T. M. File","year":"1983","unstructured":"File, T. M., Tan, J. S. Cefoperazone for the treatment of acute urinary tract infection: Multicentered comparative and noncomparative studies. Rev. Infect. Dis. 5 Suppl. (1983) S145-S153.","journal-title":"Rev. Infect. Dis."},{"issue":"Suppl.","key":"CR11","doi-asserted-by":"crossref","first-page":"S137","DOI":"10.1093\/clinids\/5.Supplement_1.S137","volume":"5","author":"W. G. Gardner","year":"1983","unstructured":"Gardner, W. G. Multicentered clinical evaluation of cefoperazone for the treatment of lower respiratory tract infections. Rev. Infect. Dis. 5 Suppl. (1983) S137-S144.","journal-title":"Rev. Infect. Dis."},{"issue":"Suppl.","key":"CR12","doi-asserted-by":"crossref","first-page":"S188","DOI":"10.1093\/clinids\/5.Supplement_1.S188","volume":"5","author":"A. J. Gordon","year":"1983","unstructured":"Gordon, A. J., Phyfferoen, M. Cefoperazone sodium in the treatment of serious bacterial infections in 2,100 adults and children: Multicentered trials in Europe, Latin America, and Australasia. Rev. Infect. Dis. 5 Suppl. (1983) S188-S199.","journal-title":"Rev. Infect. Dis."},{"key":"CR13","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1128\/AAC.26.6.870","volume":"26","author":"M. Piccart","year":"1984","unstructured":"Piccart, M., Klastersky, J., Meunier, F., Lagast, H., VanLaethem, Y., Weerts, D. Single-drug versus combination empirical therapy for gram-negative bacilliary infections in febrile cancer patients with and without graunulocytopenia. Antimicrob. Agents Chemother. 26 (1984) 870\u2013875.","journal-title":"Antimicrob. Agents Chemother."},{"issue":"Suppl.","key":"CR14","doi-asserted-by":"crossref","first-page":"S154","DOI":"10.1093\/clinids\/5.Supplement_1.S154","volume":"5","author":"L. J. Strausbaugh","year":"1983","unstructured":"Strausbaugh, L. J., Llorens, A. S. Cefoperazone therapy for obstetric and gynecologic infections. Rev. Infect. Dis. 5 Suppl. (1983) S154-S158.","journal-title":"Rev. Infect. Dis."},{"issue":"Suppl.","key":"CR15","doi-asserted-by":"crossref","first-page":"S173","DOI":"10.1093\/clinids\/5.Supplement_1.S173","volume":"5","author":"J. W. Warren","year":"1983","unstructured":"Warren, J. W., Miller, E. H., Jr., Fitzpatrick, B., DiFranco, D. E., Caplan, E. S., Tenney, J. H., Anthony, W. C. A randomized, controlled trial of cefoperazone vs. cefamandole-tobramycin in the treatment of putative, severe infections with gram-negative bacilli. Rev. Infect. Dis. 5 Suppl. (1983) S173-S180.","journal-title":"Rev. Infect. Dis."},{"key":"CR16","first-page":"28","volume":"33","author":"R. W. Geckler","year":"1983","unstructured":"Geckler, R. W., Salkeld, J. S., Goodman, J. S. Clinical evaluation of cefotaxime in a community hospital. Curr. Ther. Res. 33 (1983) 28\u201338.","journal-title":"Curr. Ther. Res."},{"key":"CR17","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1128\/AAC.21.1.119","volume":"21","author":"P. H. Karakusis","year":"1982","unstructured":"Karakusis, P. H., Feczko, J. M., Goodman, L. J., Hanlon, D. M., Harris, A. A., Levin, S., Trenholme, G. M. Clinical efficacy of cefotaxime in serious infections. Antimicrob. Agents Chemother. 21 (1982) 199\u2013224.","journal-title":"Antimicrob. Agents Chemother."},{"key":"CR18","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1128\/AAC.21.2.327","volume":"21","author":"C. J. Schleupner","year":"1982","unstructured":"Schleupner, C. J., Engle, J. E. Clinical evaluation of cefotaxime in therapy of lower respiratory tract infections. Antimicrob. Agents Chemother. 21 (1982) 327\u2013333.","journal-title":"Antimicrob. Agents Chemother."},{"issue":"Suppl.","key":"CR19","doi-asserted-by":"crossref","first-page":"S481","DOI":"10.1093\/clinids\/4.Supplement_2.S481","volume":"4","author":"C. R. Smith","year":"1982","unstructured":"Smith, C. R. Cefotaxime and cephalosporins: Adverse reactions in perspective. Rev. Infect. Dis. 4 Suppl. (1982) S481-S488.","journal-title":"Rev. Infect. Dis."},{"key":"CR20","doi-asserted-by":"crossref","first-page":"469","DOI":"10.7326\/0003-4819-101-4-469","volume":"101","author":"C. R. Smith","year":"1984","unstructured":"Smith, C. R., Ambinder, R., Lipsky, J. J., Petty, B. G., Isreal, E., Levitt, R., Mellits, E. D., Rocca, L., Longstreth, J., Lietman, P. S. Cefotaxime compared with nafcillin plus tobramycin for serious bacterial infections. Ann. Intern. Med. 101 (1984) 469\u2013477.","journal-title":"Ann. Intern. Med."},{"issue":"Suppl. A","key":"CR21","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1093\/jac\/12.suppl_A.101","volume":"12","author":"V. Fainstein","year":"1983","unstructured":"Fainstein, V., Bodey, G. P., Elting, L., Bolivar, R., Keating, M. J., McCredie, K. B., Valdivieso, M. A randomized study of ceftazidime compared to ceftazidime and tobramycin for the treatment of infections in cancer patients. J. Antimicrob. Chemother. 12 Suppl. A (1983) 101\u2013110.","journal-title":"J. Antimicrob. Chemother."},{"issue":"Suppl. A","key":"CR22","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1093\/jac\/12.suppl_A.399","volume":"12","author":"R. D. Foord","year":"1983","unstructured":"Foord, R. D. Ceftazidime: Aspects of efficacy and tolerance. J. Antimicrob. Chemother. 12 Suppl. A (1983) 399\u2013403.","journal-title":"J. Antimicrob. Chemother."},{"issue":"Suppl. A","key":"CR23","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/jac\/12.suppl_A.81","volume":"12","author":"R. Ramphal","year":"1983","unstructured":"Ramphal, R., Kramer, B. S., Rand, K. H., Weiner, R. S., Shands, J. W., Jr. Early results of a comparative trial of ceftazidime versus cephalothin, carbenicillin and gentamicin in the treatment of febrile granulocytopenic patients. J. Antimicrob. Chemother. 12 Suppl. A (1983) 81\u201388.","journal-title":"J. Antimicrob. Chemother."},{"key":"CR24","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1159\/000238222","volume":"29","author":"E. Bouza","year":"1983","unstructured":"Bouza, E., Martinez-Beltran, J., Rodriguez-Creixems, M., Loza, E., Perez del Rio, J., Guerrero, A., Hospital, J. S. Evaluation of lamoxactam in the treatment of severe bacterial infections. Chemotherapy 29 (1983) 373\u2013383.","journal-title":"Chemotherapy"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3109\/00365548409068413","volume":"16","author":"A. DeMaria","year":"1984","unstructured":"DeMaria, A., McCabe, W. R. A clinical study of moxalactam in the treatment of infections due to gram-negative bacilli. Scand. J. Infect. Dis. 16 (1984) 83\u201397.","journal-title":"Scand. J. Infect. Dis."},{"key":"CR26","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1001\/archinte.1984.00350210078014","volume":"144","author":"V. Fainstein","year":"1984","unstructured":"Fainstein, V., Bodey, G. P., Bolivar, R., Elting, L., McCredie, K. B., Keating, M. J. Moxalactam plus ticarcillin or tobramycin for treatment of febrile episodes in neutropenic cancer patients. Arch. Intern. Med. 144 (1984) 1766\u20131770.","journal-title":"Arch. Intern. Med."},{"key":"CR27","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1128\/AAC.22.1.32","volume":"22","author":"A. S. Lea","year":"1982","unstructured":"Lea, A. S., Sudan, A. W., Wood, B. A., Gentry, L. O. Randomized comparative study of moxalactam and cefazolin in the treatment of acute urinary tract infections in adults. Antimicrob. Agents Chemother. 22 (1982) 32\u201335.","journal-title":"Antimicrob. Agents Chemother."},{"key":"CR28","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1128\/AAC.21.4.650","volume":"21","author":"R. L. Marier","year":"1982","unstructured":"Marier, R. L., Faro, S., Sanders, C. V., Williams, W., Derks, F., Janney, A., Aldridge, K. Moxalactam in the therapy of serious infections. Antimicrob. Agents Chemother. 21 (1982) 650\u2013654.","journal-title":"Antimicrob. Agents Chemother."},{"key":"CR29","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1128\/AAC.21.5.780","volume":"21","author":"G. E. Mathisen","year":"1982","unstructured":"Mathisen, G. E., Meyer, R. D., Thompson, J. M., Finegold, S. M. Clinical evaluation of moxalactam. Antimicrob. Agents Chemother. 21 (1982) 780\u2013786.","journal-title":"Antimicrob. Agents Chemother."},{"key":"CR30","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1128\/AAC.24.4.494","volume":"24","author":"R. G. Penn","year":"1983","unstructured":"Penn, R. G., Preheim, L. C., Sanders, C. C., Giger, D. K. Comparison of moxalactam and gentamicin in the treatment of complicated urinary tract infections. Antimicrob. Agents Chemother. 24 (1983) 494\u2013499.","journal-title":"Antimicrob. Agents Chemother."},{"key":"CR31","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/0002-9343(83)90957-9","volume":"74","author":"B. S. Ribner","year":"1983","unstructured":"Ribner, B. S., Raeder, R., Becker, T. M., Freimer, E. H. Treatment of serious infection with moxalactam. Am. J. Med. 74 (1983) 396\u2013400.","journal-title":"Am. J. Med."},{"key":"CR32","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1128\/AAC.23.4.565","volume":"23","author":"W. Salzer","year":"1983","unstructured":"Salzer, W., Pegram, P. S., Jr., McCall, C. E. Clinical evaluation of moxalactam: Evidence of decreased efficacy in gram-positive aerobic infections. Antimicrob. Agents Chemother. 23 (1983) 565\u2013570.","journal-title":"Antimicrob. Agents Chemother."},{"key":"CR33","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1001\/archinte.1983.00350090158027","volume":"143","author":"E. Thomas","year":"1983","unstructured":"Thomas, E. Enterococcal liver abscess associated with moxalactam therapy. Review of literature on enterococcal superinfections in association with moxalactam therapy. Arch. Intern. Med. 143 (1983) 1780\u20131781.","journal-title":"Arch. Intern. Med."},{"key":"CR34","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1159\/000237993","volume":"27","author":"G. H. Trager","year":"1981","unstructured":"Trager, G. H., Panwalker, A. P., Malow, J. B., Porembski, P. E., Ramirez, C. A., Zar, F. A. Clinical efficacy of moxalactam with emphasis on infections due to multidrug-resistant organisms in patients with renal insufficiency. Chemotherapy 27 (1981) 287\u2013295.","journal-title":"Chemotherapy"},{"key":"CR35","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/BF01641201","volume":"11","author":"P. Auwera Van der","year":"1983","unstructured":"Van der Auwera, P., Clumeck, N., Van Laethem, Y., Vanhoof, R., Butzler, J. P. Moxalactam therapy of serious infections. Infection 11 (1983) 212\u2013218.","journal-title":"Infection"},{"key":"CR36","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S0025-6196(12)61427-X","volume":"59","author":"W. R. Wilson","year":"1984","unstructured":"Wilson, W. R., Henry, N. K., Keys, T. F., Anhalt, J. P., Cockerill, F. R. III, Edson, R. S., Geraci, J. E., Hermans, P. E., Muller, S. M., Rosenblatt, J. E. Empiric therapy with moxalactam alone in patients with bacteremia. Mayo Clin. Proc. 59 (1984) 318\u2013326.","journal-title":"Mayo Clin. Proc."},{"key":"CR37","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/0002-9343(84)90100-1","volume":"77","author":"D. J. Winston","year":"1984","unstructured":"Winston, D. J., Barnes, R. C., Ho, W. G., Young, L. S., Champlin, R. E., Gale, R. P. Moxalactam plus piperacillin versus moxalactam plus amikacin in febrile granulocytopenic patients. Am. J. Med. 77 (1984) 442\u2013450.","journal-title":"Am. J. Med."},{"key":"CR38","first-page":"836","volume":"136","author":"R. Yogev","year":"1982","unstructured":"Yogev, R., Schreiber, M., Gardner, S., Shulman, S. T. Moxalactam in the treatment of pediatric infections. Am. J. Dis. Child. 136 (1982) 836\u2013839.","journal-title":"Am. J. Dis. Child."},{"key":"CR39","doi-asserted-by":"crossref","first-page":"784","DOI":"10.7326\/0003-4819-94-6-784","volume":"94","author":"V. L. Yu","year":"1981","unstructured":"Yu, V. L. Enterococcal superinfection and colonization after therapy with moxalactam, a new broad-spectrum antibiotic. Ann. Intern. Med. 94 (1981) 784\u2013785.","journal-title":"Ann. Intern. Med."},{"key":"CR40","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1093\/jac\/11.suppl_B.183","volume":"11","author":"C. E. Cox","year":"1983","unstructured":"Cox, C. E. A comparison of azlocillin and ticarcillin in the treatment of complicated urinary tract infections. J. Antimicrob. Chemother. 11 (1983) 183\u2013188.","journal-title":"J. Antimicrob. Chemother."},{"key":"CR41","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1128\/AAC.24.3.388","volume":"24","author":"M. J. Gribble","year":"1983","unstructured":"Gribble, M. J., Chow, A. W., Naiman, S. C. Prospective randomized trial of piperacillin monotherapy versus carboxypenicillin aminoglycoside combination regimens in the empirical treatment of serious bacterial infections. Antimicrob. Agents Chemother. 24 (1983) 388\u2013393.","journal-title":"Antimicrob. Agents Chemother."},{"key":"CR42","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/jac\/9.suppl_A.267","volume":"9","author":"C. A. Konopka","year":"1982","unstructured":"Konopka, C. A., Arcieri, G., Schacht, P. Clinical experience with mezlocillin in Europe \u2014 overview. J. Antimicrob. Chemother. 9 (1982) 267\u2013272.","journal-title":"J. Antimicrob. Chemother."},{"key":"CR43","first-page":"65","volume":"445","author":"Y. Naide","year":"1977","unstructured":"Naide, Y., Nasakubo, I., Suzuki, K., Niimura, K. Ticarcillin in the treatment of urinary tract infections. Excerpta Medica. 445 (1977) 65\u201372.","journal-title":"Excerpta Medica."},{"key":"CR44","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/jac\/12.suppl_D.149","volume":"12","author":"H. C. Neu","year":"1983","unstructured":"Neu, H. C. Clinical perspectives on imipenem. J. Antimicrob. Chemother. 12 (1983) 149\u2013153.","journal-title":"J. Antimicrob. Chemother."},{"key":"CR45","first-page":"868","volume":"I","author":"A. Schreiner","year":"1984","unstructured":"Schreiner, A., Olsen, T., Madsen, S. T. Imipenem\/cilastatin versus gentamicin\/clindamycin for treatment of serious bacterial infections. Report from a Scandinavian Study Group. Lancet I (1984) 868\u2013871.","journal-title":"Lancet"},{"key":"CR46","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3949\/ccjm.47.4.311","volume":"47","author":"A. L. Barry","year":"1980","unstructured":"Barry, A. L., Thornsberry, C., Jones, R. N., Gavan, T. L. In vitro activity of mezlocillin and azlocillin compared to that of four other penicillins and two aminoglycosides. Cleve. Clin. Q. 47 (1980) 311\u2013319.","journal-title":"Cleve. Clin. Q."},{"issue":"Suppl. B","key":"CR47","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1093\/jac\/8.suppl_B.91","volume":"8","author":"A. W. Chow","year":"1981","unstructured":"Chow, A. W., Bartlett, K. H. Comparativein vitro activity of ceftazidime (GR-20263) and other beta-lactamase stable cephalosporins against anaerobic bacteria. J. Antimicrob. Chemother. 8 Suppl. B (1981) 91\u201395.","journal-title":"J. Antimicrob. Chemother."},{"key":"CR48","volume-title":"Tentative standard M7-T. Standard methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically","author":"National Committee for Clinical Laboratory Standards.","year":"1982","unstructured":"National Committee for Clinical Laboratory Standards. Tentative standard M7-T. Standard methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. National Committee for Clinical Labortory Standards, Villanova, Pa. (1982)."},{"key":"CR49","volume-title":"Tentative standard M2-T3. Performance standards for antimicrobic disk susceptibility tests","author":"National Committee for Clinical Laboratory Standards.","year":"1983","unstructured":"National Committee for Clinical Laboratory Standards. Tentative standard M2-T3. Performance standards for antimicrobic disk susceptibility tests. 3rd. ed. National Committee for Clinical Laboratory Standards. Villanova, Pa. (1983).","edition":"3rd. ed."},{"key":"CR50","doi-asserted-by":"crossref","first-page":"85S","DOI":"10.1016\/0732-8893(84)90002-6","volume":"2","author":"R. C. Moellering Jr.","year":"1984","unstructured":"Moellering, R. C., Jr., Eliopoulos, G. M. Activity of cefotaxime against enterococci. Diagn. Microbiol. Infect. Dis. 2 (1984) 85S-90S.","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"CR51","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1128\/JCM.18.4.858-865.1983","volume":"18","author":"D. F. Sahm","year":"1983","unstructured":"Sahm, D. F., Baker, C. N., Jones, R. N., Thornsberry, C. Medium-dependent zone size discrepancies associated with susceptibility testing of group D streptococci against various cephalosporins. J. Clin. Microbiol. 18 (1983) 858\u2013865.","journal-title":"J. Clin. Microbiol."},{"key":"CR52","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1128\/JCM.20.3.561-567.1984","volume":"20","author":"D. F. Sahm","year":"1984","unstructured":"Sahm, D. F., Baker, C. N., Jones, R. N., Thornsberry, C. Influence of growth medium on thein vitro activities of second and third-generation cephalosporins againstStreptococcus faecalis. J. Clin. Microbiol. 20 (1984) 561\u2013567.","journal-title":"J. Clin. Microbiol."},{"key":"CR53","doi-asserted-by":"crossref","first-page":"75S","DOI":"10.1016\/0732-8893(84)90026-9","volume":"2","author":"C. Thornsberry","year":"1984","unstructured":"Thornsberry, C., Sahm, D. F. Effect of media and blood on the antimicrobial activity of cephalosporins on serogroup D streptococci: A review. Diagn. Microbiol. Infect. Dis. 2 (1984) 75S-84S.","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"CR54","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1128\/AAC.18.1.88","volume":"18","author":"P. C. Fuchs","year":"1980","unstructured":"Fuchs, P. C., Barry, A. L., Thornsberry, C., Jones, R. N., Gavan, T. L., Gerlach, E. H., Sommers, H. M. Cefotaxime:in vitro activity and tentative interpretive standards for disk susceptibility testing. Antimicrob. Agents Chemother. 18 (1980) 88\u201393.","journal-title":"Antimicrob. Agents Chemother."},{"key":"CR55","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/jac\/11.suppl_B.43","volume":"11","author":"H. Grimm","year":"1983","unstructured":"Grimm, H. In vitro activity of azlocillin and other beta-lactam antibiotics against enterococci. J. Antimicrob. Chemother. 11 (1983) 43\u201346.","journal-title":"J. Antimicrob. Chemother."},{"issue":"Suppl.","key":"CR56","doi-asserted-by":"crossref","first-page":"S374","DOI":"10.1093\/clinids\/4.Supplement_2.S374","volume":"4","author":"H. C. Neu","year":"1982","unstructured":"Neu, H. C. Antibacterial activity of desacetylcefotaxime alone and in combination with cefotaxime. Rev. Infect. Dis. 4 Suppl. (1982) S374-S378.","journal-title":"Rev. Infect. Dis."},{"key":"CR57","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1128\/AAC.15.2.273","volume":"15","author":"H. E. Neu","year":"1979","unstructured":"Neu, H. E., Aswapokee, N., Aswapokee, P., Fu, K. P. HR 756, a new cephalosporin active against gram-positive and gram-negative aerobic and anaerobic bacteria. Antimicrob. Agents Chemother. 15 (1979) 273\u2013281.","journal-title":"Antimicrob. Agents Chemother."},{"key":"CR58","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1128\/AAC.14.6.807","volume":"14","author":"R. Wise","year":"1978","unstructured":"Wise, R., Rollason, T., Logan, M., Andrews, J. M., Bedford, K. A. HR 756, a highly active cephalosporin: Comparison with cefazolin and carbenicillin. Antimicrob. Agents Chemother. 14 (1978) 807\u2013811.","journal-title":"Antimicrob. Agents Chemother."},{"issue":"Suppl.","key":"CR59","doi-asserted-by":"crossref","first-page":"S366","DOI":"10.1093\/clinids\/4.Supplement_2.S366","volume":"4","author":"R. N. Jones","year":"1982","unstructured":"Jones, R. N., Barry, A. L., Thornsberry, C. Antimicrobial activity of desacetylcefotaxime alone and in combination with cefotaxime: Evidence of synergy. Rev. Infect. Dis. 4 Suppl. (1982) S366-S373.","journal-title":"Rev. Infect. Dis."},{"key":"CR60","doi-asserted-by":"crossref","first-page":"37S","DOI":"10.1016\/0732-8893(84)90021-X","volume":"2","author":"R. N. Jones","year":"1984","unstructured":"Jones, R. N., Barry, A. L., Packer, R. R. The activity of cefotaxime and desacetylcefotaxime alone and in combination against anaerobes and staphylococci. Diagn. Microbiol. Infect. Dis. 2 (1984) 37S-46S.","journal-title":"Diagn. Microbiol. Infect. Dis."}],"container-title":["Infection"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01644225.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01644225\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01644225","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T07:49:57Z","timestamp":1586245797000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01644225"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1985,1]]},"references-count":60,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[1985,1]]}},"alternative-id":["BF01644225"],"URL":"https:\/\/doi.org\/10.1007\/bf01644225","relation":{},"ISSN":["0300-8126","1439-0973"],"issn-type":[{"value":"0300-8126","type":"print"},{"value":"1439-0973","type":"electronic"}],"subject":[],"published":{"date-parts":[[1985,1]]}}}